O'Shaughnessy Asset Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-10
| Closed | – | – | 2710 |
|
|
2021
Q2 | $0 | Buy |
+10
| New | – | ﹤0.01% | 2563 |
|
|
2021
Q1 | – | Sell |
-7
| Closed | – | – | 2365 |
|
|
2020
Q4 | $0 | Sell |
7
-5,884
| -100% | – | ﹤0.01% | 2065 |
|
|
2020
Q3 | $209K | Sell |
5,891
-7,000
| -54% | -$248K | 0.01% | 682 |
|
|
2020
Q2 | $487K | Sell |
12,891
-841
| -6% | -$31.8K | 0.02% | 406 |
|
|
2020
Q1 | $399K | Sell |
13,732
-7,577
| -36% | -$220K | 0.01% | 326 |
|
|
2019
Q4 | $1.1M | Buy |
21,309
+3,110
| +17% | +$161K | 0.02% | 257 |
|
|
2019
Q3 | $999K | Buy |
+18,199
| New | +$999K | 0.02% | 265 |
|
|
2018
Q3 | – | Sell |
-5,177
| Closed | -$164K | – | 898 |
|
|
2018
Q2 | $164K | Sell |
5,177
-7,559
| -59% | -$239K | ﹤0.01% | 570 |
|
|
2018
Q1 | $633K | Sell |
12,736
-41
| -0.3% | -$2.04K | 0.01% | 310 |
|
|
2017
Q4 | $689K | Buy |
12,777
+7,241
| +131% | +$390K | 0.02% | 331 |
|
|
2017
Q3 | $321K | Buy |
5,536
+604
| +12% | +$35K | 0.01% | 432 |
|
|
2017
Q2 | $243K | Sell |
4,932
-7,502
| -60% | -$370K | 0.01% | 483 |
|
|
2017
Q1 | $540K | Sell |
12,434
-1,526
| -11% | -$66.3K | 0.01% | 347 |
|
|
2016
Q4 | $683K | Sell |
13,960
-6,183
| -31% | -$303K | 0.02% | 314 |
|
|
2016
Q3 | $964K | Buy |
20,143
+2,203
| +12% | +$105K | 0.02% | 275 |
|
|
2016
Q2 | $962K | Buy |
17,940
+14,332
| +397% | +$769K | 0.02% | 275 |
|
|
2016
Q1 | $162K | Buy |
+3,608
| New | +$162K | ﹤0.01% | 485 |
|
|
2015
Q2 | – | Sell |
-8,285
| Closed | -$341K | – | 970 |
|
|
2015
Q1 | $341K | Sell |
8,285
-11,027
| -57% | -$454K | 0.01% | 433 |
|
|
2014
Q4 | $784K | Sell |
19,312
-20,391
| -51% | -$828K | 0.02% | 349 |
|
|
2014
Q3 | $1.45M | Sell |
39,703
-6,195
| -13% | -$227K | 0.03% | 289 |
|
|
2014
Q2 | $2.13M | Buy |
45,898
+4,196
| +10% | +$194K | 0.04% | 252 |
|
|
2014
Q1 | $1.71M | Buy |
41,702
+17,708
| +74% | +$727K | 0.03% | 259 |
|
|
2013
Q4 | $914K | Buy |
+23,994
| New | +$914K | 0.02% | 337 |
|